Neuronetics Stock In The News

STIM Stock  USD 0.89  0.05  5.95%   
Our overall analysis of Neuronetics' news coverage and content from conventional and social sources shows investors' bearish mood towards Neuronetics. The specific impact of Neuronetics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Neuronetics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Neuronetics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Neuronetics Backtesting and Neuronetics Hype Analysis.
To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.

Neuronetics Today Top News and Investor Outlook

Yahoo News
3 Neurotech Stocks Bridging Mind and Machine
https://finance.yahoo.com/news/3-neurotech-stocks-bridging-mind-143000910.html
 Bullish
Macroaxis News: globenewswire.com
Neuronetics to Present at the 35th Annual Piper Sandler Healthcare Conference
https://www.globenewswire.com/news-release/2023/11/15/2781416/0/en/Neuronetics-to-Present-at-the-35th-Annual-Piper-Sandler-Healthcare-Conference.html
 Neutral
Macroaxis News: globenewswire.com
NeuroStar Elevates Depression Treatment with Cutting-Edge Technology Advancements
https://www.globenewswire.com/news-release/2023/11/13/2779092/0/en/NeuroStar-Elevates-Depression-Treatment-with-Cutting-Edge-Technology-Advancements.html
 Bullish
Macroaxis News: globenewswire.com
Neuronetics Announces Continued Momentum from Health Plans for TMS Therapy Coverage
https://www.globenewswire.com/news-release/2023/11/09/2777387/0/en/Neuronetics-Announces-Continued-Momentum-from-Health-Plans-for-TMS-Therapy-Coverage.html
 Neutral
Macroaxis News: globenewswire.com
Neuronetics Reports Third Quarter 2023 Financial and Operating Results
https://www.globenewswire.com/news-release/2023/11/07/2774966/0/en/Neuronetics-Reports-Third-Quarter-2023-Financial-and-Operating-Results.html
 Bullish
Macroaxis News: globenewswire.com
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
https://www.globenewswire.com/news-release/2023/11/06/2774567/0/en/Neuronetics-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html
 Neutral
Macroaxis News: globenewswire.com
Neuronetics to Report Third Quarter 2023 Financial and Operating Results and Host Conference Call
https://www.globenewswire.com/news-release/2023/10/24/2765615/0/en/Neuronetics-to-Report-Third-Quarter-2023-Financial-and-Operating-Results-and-Host-Conference-Call.html
 Neutral
Macroaxis News: globenewswire.com
Brain Stimulation Highlights Best Practices for Optimal TMS Treatment Outcomes
https://www.globenewswire.com/news-release/2023/10/16/2760687/0/en/Brain-Stimulation-Highlights-Best-Practices-for-Optimal-TMS-Treatment-Outcomes.html
 Bullish
Macroaxis News: globenewswire.com
Neuronetics Draws Down Remaining $22.5 Million Available Under Credit Facility
https://www.globenewswire.com/news-release/2023/10/03/2753772/0/en/Neuronetics-Draws-Down-Remaining-22-5-Million-Available-Under-Credit-Facility.html
 Neutral
Macroaxis News: globenewswire.com
In Recognition of Suicide Prevention Month, NeuroStar Voices Portal Amplifies Stories of Real People Beating Depression
https://www.globenewswire.com/news-release/2023/09/12/2741698/0/en/In-Recognition-of-Suicide-Prevention-Month-NeuroStar-Voices-Portal-Amplifies-Stories-of-Real-People-Beating-Depression.html
 Neutral

Neuronetics Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Neuronetics and other traded companies coverage with news coverage. We help investors stay connected with Neuronetics headlines for the 22nd of November to make an informed investment decision based on correlating the impacts of news items on Neuronetics Stock performance. Please note that trading solely based on the Neuronetics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Neuronetics' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Neuronetics investors visualize upcoming and past events in order to time the market based on Neuronetics noise-free hype analysis.
Neuronetics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Neuronetics earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Neuronetics that are available to investors today. That information is available publicly through Neuronetics media outlets and privately through word of mouth or via Neuronetics internal channels. However, regardless of the origin, that massive amount of Neuronetics data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Neuronetics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Neuronetics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Neuronetics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Neuronetics alpha.

Neuronetics Largest EPS Surprises

Earnings surprises can significantly impact Neuronetics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-05-07
2024-03-31-0.31-0.270.0412 
2021-08-03
2021-06-30-0.24-0.29-0.0520 
2021-03-02
2020-12-31-0.24-0.190.0520 
2024-08-12
2024-06-30-0.27-0.33-0.0622 
2019-11-05
2019-09-30-0.43-0.370.0613 
2024-03-05
2023-12-31-0.26-0.190.0726 
View All Earnings Estimates

Neuronetics Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Neuronetics Stock. Current markets are strongly bullish. About 82% of major world exchanges and indexes are currently up. See today's market update for more information.
Gurufocus Stories at Macroaxis
20th of November 2024
Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference
at gurufocus.com 
Gurufocus Stories at Macroaxis
15th of November 2024
CANNELL CAPITAL LLC Adjusts Stake in Neuronetics Inc
at gurufocus.com 
Investing News at Macroaxis
13th of November 2024
Earnings call Neuronetics reports revenue growth amidst strategic shifts
at investing.com 
Macroaxis News: globenewswire.com
12th of November 2024
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635
at globenewswire.com 
Gurufocus Stories at Macroaxis
11th of November 2024
Neuronetics Inc Q3 2024 Earnings Report Preview What to Expect
at gurufocus.com 
Macroaxis News
7th of November 2024
Acquisition by Conley Sheryl L of 25000 shares of Neuronetics subject to Rule 16b-3
at MacroaxisInsider 
Yahoo News
4th of October 2024
Neuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Ar...
at finance.yahoo.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Neuronetics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Neuronetics' short interest history, or implied volatility extrapolated from Neuronetics options trading.
When determining whether Neuronetics is a strong investment it is important to analyze Neuronetics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Neuronetics' future performance. For an informed investment choice regarding Neuronetics Stock, refer to the following important reports:
Check out Neuronetics Backtesting and Neuronetics Hype Analysis.
To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuronetics. If investors know Neuronetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuronetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.22)
Revenue Per Share
2.453
Quarterly Revenue Growth
(0.07)
Return On Assets
(0.17)
Return On Equity
(1.00)
The market value of Neuronetics is measured differently than its book value, which is the value of Neuronetics that is recorded on the company's balance sheet. Investors also form their own opinion of Neuronetics' value that differs from its market value or its book value, called intrinsic value, which is Neuronetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuronetics' market value can be influenced by many factors that don't directly affect Neuronetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neuronetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuronetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuronetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.